With the Centre willing to rewrite the rules related to sale of prescription drugs, the decks are being cleared for their online sales. In an industry meeting in New Delhi on June 17, Dr. G.N. Singh, the Drugs Controller General (India), said the pharmaceutical industry needs a new regulatory framework to bring e-pharmacy under its ambit. The Drugs and Cosmetics Act, 1945, does not have any provision for online sale of drugs. The regulator is planning to discuss and develop the guidelines within a few months in consultation with various stakeholders, including doctors, retailers, pharmacists and drug manufacturers. "The interests of small retailers will be protected and it will be ensured that e-pharmacy does not disturb the existing supply chain system. The aim would be to integrate e-pharmacy in the existing system," says Singh.
"PRESSURE FROM INDUSTRY LOBBIES IS MOUNTING ON THE REGULATOR TO ALLOW SALE OF DRUGS ONLINE"
"THE CENTRE MUST BRING IN FOOL-PROOF LAWS, SYSTEMS AND PROCESSES. ELSE, THERE ARE CHANCES OF MISUSE"
In May 2015, the Maharashtra Food and Drug Administration (FDA) had filed a case against e-commerce major Snapdeal for selling drugs. The Gujarat FDA, too, initiated action against online pharmacies. "By law, there is nothing called an e-pharmacy and, hence, there are no guidelines required to regulate them. If a patient orders sleeping pills online and takes an extra dose, who will be held responsible?" asks Maharashtra FDA Commissioner Harshdeep Kamble.Recently, the Interpol, in a joint operation with other local international law enforcement agencies, initiated action against online pharmacies in 114 countries, closing down over 2,400 sites. From July 1, the European Union has mandated registration of such operators with regulatory authorities. The US FDA, too, recently took action against 400 online pharmacies. The US has comprehensive laws covering e-health and telemedicine.
"The drug distribution industry in India is poised to grow to $55 billion by 2020 and there is no harm in technology acting as an enabler in offering convenience to customers," says Phaneesh Murthy, Chairman of the soon-to-be-launched e-health exchange, PM Health & Life Care, and former i-Gate CEO. "Our lawyers studied the business plan and model. We have devised a system which complies with existing rules. Some former regulatory officials also vetted our system and found it fool-proof," says Hemant Kumar Bhardwaj, Chief Executive of PM Health.
"We will not sell physically to a customer, but note that no medical store keeps a record of prescriptions. It is a fact that patients order drugs over telephone and neighbourhood pharmacies deliver them. Then why is there such a big fuss about this model, which is convenient and customer-friendly?" says Pradeep Dadha, promoter of Netmed, a recently-launched online pharmacy based in Chennai. It has tied up with India Post to deliver drugs across India.
Experts say India is not mature enough to allow online sale of drugs. Unless the central government brings in fool-proof processes, there are chances of misuse, which can cause serious social issues.
Rs 83,000 crore
Size of drug distribution business in India
Rs 3,46,500 crore
Online drug sales
are illegal in India under existing rules